Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $673.3050 (-0.31%) ($671.7900 - $673.3050) on Wed. Apr. 27, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.5% (three month average) | RSI | 40 | Latest Price | $673.3050(-0.31%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1.3% a day on average for past five trading days. | Weekly Trend | REGN declines -2.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(58%) DIA(40%) IWD(39%) SPY(38%) XLV(38%) | Factors Impacting REGN price | REGN will decline at least -0.75% in a week (0% probabilities). VIXM(-19%) TBT(-13%) UUP(-8%) VXX(-3%) USO(2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.75% (StdDev 1.5%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $706.92 | 5 Day Moving Average | $686.5(-1.92%) | 10 Day Moving Average | $704.08(-4.37%) | 20 Day Moving Average | $706.92(-4.76%) | To recent high | -8.9% | To recent low | 11.7% | Market Cap | $71.39b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |